As of 2025-09-16, the EV/EBITDA ratio of Medipharm Labs Corp (LABS.TO) is -2.61. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. LABS.TO's latest enterprise value is 21.74 mil CAD. LABS.TO's TTM EBITDA according to its financial statements is -8.34 mil CAD. Dividing these 2 quantities gives us the above LABS.TO EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 16.0x - 18.9x | 17.4x |
| Forward P/E multiples | 17.7x - 36.9x | 27.3x |
| Fair Price | (0.33) - (0.35) | (0.42) |
| Upside | -536.6% - -567.3% | -660.1% |
| Date | EV/EBITDA |
| 2025-09-11 | -2.61 |
| 2025-09-10 | -2.35 |
| 2025-09-09 | -2.61 |
| 2025-09-08 | -2.35 |
| 2025-09-05 | -2.61 |
| 2025-09-04 | -2.35 |
| 2025-09-03 | -2.35 |
| 2025-09-02 | -2.35 |
| 2025-08-29 | -2.86 |
| 2025-08-28 | -2.61 |
| 2025-08-27 | -2.61 |
| 2025-08-26 | -2.61 |
| 2025-08-25 | -2.61 |
| 2025-08-22 | -2.61 |
| 2025-08-21 | -2.61 |
| 2025-08-20 | -2.61 |
| 2025-08-19 | -2.61 |
| 2025-08-18 | -2.61 |
| 2025-08-15 | -2.86 |
| 2025-08-14 | -2.86 |
| 2025-08-13 | -3.36 |
| 2025-08-12 | -2.61 |
| 2025-08-11 | -2.35 |
| 2025-08-08 | -2.35 |
| 2025-08-07 | -2.10 |
| 2025-08-06 | -2.35 |
| 2025-08-05 | -2.35 |
| 2025-08-01 | -2.10 |
| 2025-07-31 | -2.35 |
| 2025-07-30 | -2.35 |
| 2025-07-29 | -2.10 |
| 2025-07-28 | -2.35 |
| 2025-07-25 | -2.35 |
| 2025-07-24 | -2.35 |
| 2025-07-23 | -2.35 |
| 2025-07-22 | -2.10 |
| 2025-07-21 | -2.35 |
| 2025-07-18 | -2.35 |
| 2025-07-17 | -2.35 |
| 2025-07-16 | -2.35 |
| 2025-07-15 | -2.35 |
| 2025-07-14 | -2.35 |
| 2025-07-11 | -2.10 |
| 2025-07-10 | -2.10 |
| 2025-07-09 | -2.10 |
| 2025-07-08 | -2.10 |
| 2025-07-07 | -2.10 |
| 2025-07-04 | -2.10 |
| 2025-07-03 | -2.10 |
| 2025-07-02 | -2.35 |